| Print
Standard BioTools (LAB)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Address
7000 Shoreline Court
Suite 100
South San Francisco
CA
USA
94080
Telephone
+1 650 2666000
Forecast key dates
| Name | Key Date |
|---|---|
| Standard BioTools Inc Third Quarter Earnings Results for 2026 | 2026-11-04T00:00:00 |
| Standard BioTools Inc Third Quarter Earnings Conference Call for 2026 | 2026-11-04T00:00:00 |
| Standard BioTools Inc Second Quarter Earnings Conference Call for 2026 | 2026-08-11T16:30:00 |
| Standard BioTools Inc Second Quarter Earnings Results for 2026 | 2026-08-11T00:00:00 |
| Standard BioTools Inc Annual General Meeting for 2026 | 2026-06-18T08:30:00 |
| Standard BioTools Inc First Quarter Earnings Conference Call for 2026 | 2026-05-06T16:30:00 |
| Standard BioTools Inc First Quarter Earnings Results for 2026 | 2026-05-06T00:00:00 |
| Standard BioTools Inc Annual Report for 2025 | 2026-03-11T00:00:00 |
| Standard BioTools Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-02-26T16:30:00 |
| Standard BioTools Inc Fourth Quarter Earnings Results for 2025 | 2026-02-26T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Standard BioTools Inc Third Quarter Earnings Result for 2025 | 2025-11-04T00:00:00 |
| Standard BioTools Inc Third Quarter Earnings Conference Call for 2025 | 2025-11-04T00:00:00 |
| Standard BioTools Inc Second Quarter Earnings Results for 2025 | 2025-08-11T00:00:00 |
| Standard BioTools Inc Annual General Meeting for 2025 | 2025-06-18T08:30:00 |
| Standard BioTools Inc First Quarter Earnings Conference Call for 2025 | 2025-05-06T16:30:00 |
| Standard BioTools Inc First Quarter Earnings Result for 2025 | 2025-05-06T00:00:00 |
| KeyBanc's 5th Annual Healthcare Forum | 2025-03-19T16:30:00 |
| 2025 Leerink Partners Global Healthcare Conference | 2025-03-12T15:10:00 |
| Standard BioTools Inc Annual Report for 2024 | 2025-03-11T00:00:00 |
| TD Cowen's 45th Annual Healthcare Conference | 2025-03-03T15:10:00 |
| Standard BioTools Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-02-26T16:30:00 |
| Standard BioTools Inc Fourth Quarter Earnings Result for 2024 | 2025-02-26T00:00:00 |
| 43rd Annual J.P. Morgan Healthcare Conference | 2025-01-16T09:45:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.